Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Post by Hiddensecretson Mar 18, 2021 6:31pm
134 Views
Post# 32834776

COVID19 TESTING sites are an investment in a DYING BUSINESS

COVID19 TESTING sites are an investment in a DYING BUSINESSHow long have the testing sites exceled per track record:   one (1) month which was January 2021.

Sales plunged in February 2021 and, barely scratched the surface in December 2020.  It did little to nothing in November 2020.

So the life of this business we can say is maybe one (1) quarter.   A depanneur has a longer life span. 

The rest of the year will continue with plunging sales per my opinion as we are in a dying business.  

Their post covid19 business plan is all over the place, like throwing a dart on the board.  It demonstrates a lack of vision and an ineptitude at the management level.

Execution is also a soar point, management has shown that they cannot execute what they  promise, what they sign in a contract means nothing as it does not come to fruitition (ie:  743 cubes with Simon by March 2021).

With share value, they seem to have no concept that shares are a valuable currency and their constant misuse in just throwing shares away like at half price tells me that they do not know how to trade or negotiate with business people.  It is like selling your house at half price. 

In terms of shareholder communication, it is dreadful.   You put people on a webinar who are not credible, you put people who do not know how to speak english is simple manner so that everyone is lost, you put people what are all over the place with no vision going forward leaving shareholders lost.

In terms of setting metric to evaluate yourself they use what fits best at the time, taking shareholders for id*iots.

And with press releases there is a total lack of respect to ensure that what is released is credible (ie:  Karland non existent entity at time of press release).

It is time for new management because this one has no vision of the future post covid19.  They talk big but actions are little.  

My idea of growing the company is not buying a 4 employee pharmacy nor, is it to sell on Walmart a covid19 spray that is 5 times more expensive than the best one out there, nor is it to hope for some type of blowing technology that will be used who knows maybe in 2031.

I hope shareholders have learned their lesson in this stock, myself included.

You cannot trust BIG TALKERS.

MPO
<< Previous
Bullboard Posts
Next >>